Cite
[Myeloproliferative disorders "Philadelphia negative" and JAK2V617F mutation: study of 15 cases in Togo].
MLA
Padaro, Essohana, et al. “[Myeloproliferative Disorders ‘Philadelphia Negative’ and JAK2V617F Mutation: Study of 15 Cases in Togo].” Annales de Biologie Clinique, vol. 70, no. 5, Oct. 2012, pp. 591–94. EBSCOhost, https://doi.org/10.1684/abc.2012.0747.
APA
Padaro, E., Agbetiafa, K., Delagnon Kueviakoe, I. M., Layibo, Y., Amegbor, K., Vovor, A., Giraudier, S., Sanogo, I., & Segbena, A. Y. (2012). [Myeloproliferative disorders “Philadelphia negative” and JAK2V617F mutation: study of 15 cases in Togo]. Annales de Biologie Clinique, 70(5), 591–594. https://doi.org/10.1684/abc.2012.0747
Chicago
Padaro, Essohana, Kossi Agbetiafa, Irénée Messanh Delagnon Kueviakoe, Yao Layibo, Koffi Amegbor, Ahoefa Vovor, Stéphane Giraudier, Ibrahima Sanogo, and Akueté Yvon Segbena. 2012. “[Myeloproliferative Disorders ‘Philadelphia Negative’ and JAK2V617F Mutation: Study of 15 Cases in Togo].” Annales de Biologie Clinique 70 (5): 591–94. doi:10.1684/abc.2012.0747.